Clinical trial
Benefits of µCor in Ambulatory Decompensated Heart Failure
NCT03476187 · Zoll Medical Corporation, Industry · Completed
Key facts
| NCT number | NCT03476187 |
|---|---|
| Title | Benefits of µCor in Ambulatory Decompensated Heart Failure |
| Official title | Benefits of µCor in Ambulatory Decompensated Heart Failure |
| Acronym | BMADHF |
| Lead sponsor | Zoll Medical Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | µCor |
| Enrollment | 257 |
| Start date | Aug 17, 2018 |
| Primary completion | Jan 8, 2024 |
| Completion | Apr 9, 2024 |
| First posted | Mar 23, 2018 |
| Last update posted | Jan 8, 2025 |
| Countries | Austria, Germany, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: